[{"Assets_0_Q2_USD":3154300000.0,"CommonStockSharesOutstanding_0_Q2_shares":124770928.0,"NetIncomeLoss_1_Q2_USD":17400000.0,"NetIncomeLoss_2_Q2_USD":22000000.0,"StockholdersEquity_0_Q2_USD":588000000.0,"EarningsPerShareBasic_1_Q2_USD":0.14,"EarningsPerShareBasic_2_Q2_USD":0.18,"EarningsPerShareDiluted_1_Q2_USD":0.14,"EarningsPerShareDiluted_2_Q2_USD":0.17,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":96000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":126414644.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":126340803.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":124889681.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":124870327.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-Q","period":"20161231","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170206"}]